drugset / Trial / NCT00665743

Study Evaluating the Bioavailability of Naproxen 500 mg in Three Formulations

NCT00665743

Phase 1 Completed 30 enrolled POZEN
RandomizedCrossoverOpen-labelBasic science

Summary

We will evaluate the bioavailability of naproxen 500 mg administered as three dfferent formulations.

Timeline

Start
2008-03
Primary completion
2008-06
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg
Comparator Naproxen Small molecule 500 mg